Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement

28 Apr 2022

Abstract excerpt

Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukemia (BCP-ALL) carries an immunoglobulin- MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma/leukemia and use of individualized treatment schedules of unproven efficacy. Here we compare the molecular characteristics of these conditions and investigate historic clinical outcome data. We...

Topics

Join the communities discussing this publication.

Acute Lymphoblastic Leukemia research
Chronic Myeloid Leukemia Treatments
Lung Cancer Research Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35484682
DOI: 10.3324/haematol.2021.280557

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangementPMID 35484682Read ↗

IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasSemantic proximity Read ↗

New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.Semantic proximity Read ↗

Molecular characterization and biomarker identification in paediatric B-cell acute lymphoblastic leukaemia.Semantic proximity Read ↗

Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.Semantic proximity Read ↗

Genetic subtypes of B-cell acute lymphoblastic leukemia in adultsSemantic proximity Read ↗

Advances in B‐cell Precursor Acute Lymphoblastic Leukemia GenomicsSemantic proximity Read ↗

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 casesSemantic proximity Read ↗

Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.Semantic proximity Read ↗

Advances in the diagnosis and classification of B-ALL: comparative insights from updated guidelines.Semantic proximity Read ↗

B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.